U.S. researchers working on mice were able to decrease fibrosis -- the formation of collagen scar tissue -- resulting from a heart attack and improve cardiac function after suppressing the sFRP2 protein. The finding could possibly be used to make a drug that zeros in on and curbs the activity of sFRP2 to lessen heart-attack injuries in humans, one of the scientists said.

Full Story:

Related Summaries